Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

WATSON LABS

  • FDA Approval
  • Jan. 19, 2023, 12:38 UTC
  • 28
  • 0 comments

FDA approve ESTAZOLAM

Comment Full text

WATSON LABS INC

  • FDA Approval
  • Jan. 19, 2023, 12:38 UTC
  • 25
  • 0 comments

FDA approve DIAZEPAM

Comment Full text

ACTAVIS ELIZABETH

  • FDA Approval
  • Jan. 19, 2023, 12:38 UTC
  • 28
  • 0 comments

FDA approve OXAZEPAM

Comment Full text

HIKMA

  • FDA Approval
  • Jan. 19, 2023, 12:38 UTC
  • 26
  • 0 comments

FDA approve DIAZEPAM

Comment Full text

UNITED RES LABS

  • FDA Approval
  • Jan. 19, 2023, 12:38 UTC
  • 26
  • 0 comments

FDA approve OXAZEPAM

Comment Full text

SUN PHARM INDUSTRIES

  • FDA Approval
  • Jan. 19, 2023, 12:38 UTC
  • 28
  • 0 comments

FDA approve OXAZEPAM

Comment Full text

RISING

  • FDA Approval
  • Jan. 19, 2023, 12:38 UTC
  • 115
  • 0 comments

FDA approve FLURAZEPAM HYDROCHLORIDE

Comment Full text

HIKMA

  • FDA Approval
  • Jan. 19, 2023, 12:38 UTC
  • 26
  • 0 comments

FDA approve TOBRAMYCIN SULFATE

Comment Full text

HIKMA

  • FDA Approval
  • Jan. 19, 2023, 12:38 UTC
  • 26
  • 0 comments

FDA approve TOBRAMYCIN SULFATE

Comment Full text

MYLAN PHARMS INC

  • FDA Approval
  • Jan. 19, 2023, 12:38 UTC
  • 27
  • 0 comments

FDA approve AMITRIPTYLINE HYDROCHLORIDE; CHLORDIAZEPOXIDE

Comment Full text
  • Previous
  • 898
  • 899
  • 900
  • 901
  • 902
  • Next

Search

News categories

  • Technical Exchange News(12261)
  • Event(6229)
  • SEC News(265440)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(155103)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin